Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the AMGN historical prices.
The 52 Week Low is $211.71 set on Thu, Jun 1, 2023.
The 52 Week High is $329.72 set on Thu, Feb 1, 2024. The current price, $270.90, is 0% below the 52 Week High.
The All-Time High is $324.82 set on Thu, Feb 1, 2024. The current price, $270.90, is 0% below the All Time High.
Below is the most recent stock split information. View AMGN stock split history.
Stock Split Ex Date
Adjustment Factor
Below is the most recent dividend information. View complete AMGN dividend history of 52 dividend payments to shareholders.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.